Elevance Health Inc

Elevance Health’s ELV stock climbs 1.92% in 2025, outpacing the S&P 500, while rising US health‑insurance premiums shape its pricing strategy and future growth outlook.

Elevance Health appoints Amy Schulman to its board, boosting governance and funding its “Creating Healthier Communities” grant to strengthen community health initiatives.

Elevance Health Inc. faces market challenges due to Medicaid pressures and premium increases, leading to a 12% stock price drop and adjusted analyst outlook.

Elevance Health Inc. is set to announce its second-quarter 2025 earnings on July 17, with analysts expecting a 9.14% decrease in earnings per share compared to the previous year.

Elevance Health Inc. navigates a tumultuous year marked by financial fluctuations, legal challenges, and strategic moves, with a recent dividend announcement providing temporary relief to investors.